Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged &#8805; 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study.

Lawthom, Charlotte; Bermejo, Pedro; Campos, Dulce; McMurray, Rob; Villanueva, Vicente

Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study.

Lawthom, Charlotte; Bermejo, Pedro; Campos, Dulce; McMurray, Rob; Villanueva, Vicente.

Afiliación

Lawthom C; Aneurin Bevan University Health Board, Royal Gwent Hospital, Newport, UK. charlotte.lawthom2@wales.nhs.uk.
Bermejo P; Hospital Universitario Puerta de Hierro, Madrid, Spain.
Campos D; Hospital Clinico Universitario, Valladolid, Spain.
McMurray R; Eisai Europe Ltd, Hatfield, Hertfordshire, UK.
Villanueva V; Hospital Universitario y Politécnico La Fe, Valencia, Spain.

Neurol Ther ; 8(2): 491-504, 2019 Dec.

Article en En | MEDLINE | ID: mdl-31098888